Press Releases

Global Market for Women’s Health Therapeutics Expected to Reach $22.5 Billion in 2018; Postmenopausal Osteoporosis Claims 53% Market Share

May 29, 2014

Wellesley, Mass., May 29, 2014 – BCC Research( reveals in its new report,Therapeutics for Women's Health: Technologies and Global Markets, the global market for women’s health therapeutics is expected to grow to $22.5 billion by 2018, with a five-year compound annual growth rate (CAGR) of 3.5%.  The postmenopausal osteoporosis therapeutics segment leads the global market, claiming 53% market share.

Women’s health issues have gained significant market attention recently as a result of disease pattern and treatment differences between men and women. The U.S. segment, by far the largest- and fastest-growing regional market, is expected to reach $13.5 billion by 2018, registering a CAGR of 4.7%.

The European and Japanese markets are projected to approach $7.5 billion and nearly $1.4 billion, respectively, by 2018, at CAGRs of 1.7% and 1.8%.

Currently, postmenopausal osteoporosis dominates the global market for women’s health therapeutics and technologies, followed by menopause, endometriosis, and polycystic ovary syndrome, which claim 30%, 14%, and 4% of the total market, respectively.

“Patent expiry is one of the key challenges for the growth of this market and has resulted in a slowdown in recent few years due to patent expiries of blockbusters such as Evista, the Premarin family, Actonel, and other drugs,” says BCC Research biotechnology analyst Dr. Ritu Thakur Dangi. “However, the launch of novel therapies (e.g., elagolix, odanacatib, Femitra, among others) in the late-stage pipeline has the strong potential to drive the market during the forecast period.”

Therapeutics for Women's Health: Technologies and Global Marketsprovides an overview of the global market for women’s health therapeutics. It includes analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.

To Contact us, click here  

Source: BCC Research

Editors and reporters who wish to speak with the analyst, should contact Steven Cumming at

Therapeutics for Women's Health: Technologies and Global Markets( BIO043E )
Publish Date:     

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.